There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PTC Therapeutics (PTCT – Research Report), ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering.

Dermata Therapeutics (NASDAQ:DRMA) is raising ~$2.55M in a private offering priced at-the-market under Nasdaq rules. The company is offering 2,007,880 shares of its common stock (or pre-funded ...

In a report released yesterday, Joseph Schwartz from Leerink Partners maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), ...

Takeda-backed Ascentage Pharma Group (AAPG) (OTCPK:ASPHF), which is developing treatments for blood cancer, has set terms for a $170M U.S. initial public offering. In an SEC filing, Ascentage (AAPG) ...

--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that it has commenced an underwritten public offering of shares of its common stoc ...

(RTTNews) - Eterna Therapeutics (ERNA), a Massachusetts-based ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan ...

RAPT Therapeutics, a biopharmaceutical company specializing in immunology, announced that its CEO, Dr. Brian Wong, will present an overview of the company at the 43rd Annual J.P. Morgan Healthcare ...

Inc. (Nasdaq: NYMT) (the “Company”) announced today the pricing of an underwritten public offering of $75 million aggregate principal amount of its 9.125% senior notes due 2030 (the “Notes”).

Amesite Inc. raised approximately $3.6 million through a public offering of 1,201,667 shares ... Here are some of the largest recent moves: . (Nasdaq: AMST), a pioneering technology company ...

DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering ... closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock ...

in an public offering. All of the shares of common stock (and/or Pre-funded Warrants) are to be sold by the Company. Ladenburg Thalmann & Co. Inc. is acting as exclusive placement agent for the ...